Last reviewed · How we verify
NCT04185376
Prevalence and Risk Factors for Pelvic Floor Disorders
trial testing Questionnaire in Pelvic Floor Disorders in 300 participants. Completed in 10 December 2020.
30 November 2020
Quick facts
| Lead sponsor | Fayoum University Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 300 |
| Start date | 15 December 2019 |
| Primary completion | 30 November 2020 |
| Estimated completion | 10 December 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Questionnaire
Conditions studied
- Pelvic Floor Disorders — all drugs for Pelvic Floor Disorders →
Sponsor
Fayoum University Hospital
Who can join
Adults 18 to 40, female only, with Pelvic Floor Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Pelvic floor disorders (PFD) can adversely affect the quality of life of a woman and they can occur during different stages of female life such as during pregnancy, early postpartum period or during menopause. It is well known that pregnancy and vaginal birth are significant risk factors in the etiology of PFD and predicting models like UR-CHOICE score were developed for this reason to provide mothers-to-be with sufficient information regarding their subsequent risk of PFD. Pregnancy, childbirth and the immediate postpartum period, where the demands on the pelvic floor and the incidence of pelvic floor trauma are particularly high, offers an optimal opportunity for such counseling and prevention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04185376
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Questionnaire
Trials testing the same drug.
- NCT04466371 — Perceptions of Undergraduate Students and Teaching Staff on Online Teaching · suspended
- NCT07089953 — Patient Perception of Physician's Compassion, Communication Skills, and Professionalism During Clinic Visits: a Randomiz · NA · not yet recruiting
- NCT07418775 — Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma · not yet recruiting
- NCT07226804 — Nanosecond Pulsed Field Ablation in the Management of Benign Thyroid Nodules · not yet recruiting
- NCT07532954 — The Impact Of A Patient Support Community On Patients With Neuroendocrine Cervical Cancer: NECC Peer Support · recruiting
Other recruiting trials for Pelvic Floor Disorders
Currently open trials in the same condition.
- NCT07268014 — Effects of Pelvic Exercises on Birth and Incontinence · NA · recruiting
- NCT06986824 — Perineal Massage Using A Pelvic Wand During Pregnancy · Phase 4 · recruiting
- NCT07004738 — Assessment of Rectus Abdominis Muscle Thickness and Residual Bladder Volume Before and After Pelvic Floor Exercises · NA · active not recruiting
- NCT06796985 — Botox for Chronic Pelvic Pain · Phase 1 · recruiting
- NCT06808542 — Pelvic Floor Dysfunction Among Female Physiotherapy Students: A Cross-Sectional Study · recruiting
Other Fayoum University Hospital trials
Trials by the same sponsor.
- NCT07507799 — Low Versus Standard Volume EXORA Block in Laparoscopic Cholecystectomy · NA · not yet recruiting
- NCT07435870 — Analgesia Nociception Index Monitoring in Trigeminal Cardiac Reflex During Nasal Septoplasty · not yet recruiting
- NCT07442721 — Sacral ESPB vs. PENG Block for Hip Hemiarthroplasty Analgesia · NA · recruiting
- NCT07187310 — EXORA vs ESP Blocks in Laparoscopic Cholecystectomy · NA · recruiting
- NCT07205757 — Adding Lidocaine to Custodiol Mixture · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04185376 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fayoum University Hospital
- Last refreshed: 3 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04185376.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing